// App-Quantinova.ai

: Anti-Xa Level Monitoring for Treatment Dose Enoxaparin in Liver/Intestine Transplant Recipients

Researchers

Presenter

  • J. Sullivan

Principal Investigators

  • J. Jebrock

  • J. Revollo

  • M. Perez

  • J. Garcia

  • T. Beduschi

Medical Centers

  • Jackson Memorial Hospital, Miami, FL

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

Disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Enoxaparin

  • Enoxaparin sodium

Outcome

  • N/A


Study Design

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A